{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:32:13Z","timestamp":1787027533609,"version":"build-2736575974"},"reference-count":41,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA287731"],"award-info":[{"award-number":["R01CA287731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA250412"],"award-info":[{"award-number":["R01CA250412"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R37CA248018"],"award-info":[{"award-number":["R37CA248018"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"award":["R01CA287731"],"award-info":[{"award-number":["R01CA287731"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01CA250412"],"award-info":[{"award-number":["R01CA250412"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R37CA248018"],"award-info":[{"award-number":["R37CA248018"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"name":"US Department of Defense BCRP","award":["W81XWH-19-1-0674"],"award-info":[{"award-number":["W81XWH-19-1-0674"]}]},{"name":"US Department of Defense BCRP","award":["HT9425-24-1-0762"],"award-info":[{"award-number":["HT9425-24-1-0762"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Ki67 is a well-established histologic proliferation marker across many cancers; however, its clinical application in pancreatic ductal adenocarcinoma (PDAC) has remained limited. Multiple studies have demonstrated that Ki67 is prognostic in PDAC, with higher Ki67 expression associated with worsened outcomes. In this study, we aimed to characterize the underlying biology of Ki67-enriched tumors. Methods: Clinical and transcriptional data from PDAC patients were obtained from The Cancer Genome Atlas (TCGA) and three Gene Expression Omnibus (GEO) datasets. Mutational analysis from the TCGA cohort was also performed. Patients within each study were stratified into low- and high-expression groups based on the median transcript levels. Each dataset was analyzed independently, and differences between groups were subsequently compared across studies. Results: Consistent with their enhanced proliferative capacity, MKI67-high tumors were consistently enriched in pro-proliferative cellular pathways including E2F targets, MYC targets, and mitotic spindle formation as well as pro-growth metabolic pathways across all studies. MKI67-high PDAC is associated with higher histologic grading with similar pathologic staging. High expression was associated with worsened overall and disease-free survival in the TCGA cohort, although this was not consistently observed across external validation datasets. MKI67-high tumors exhibited a significantly higher mutational burden than the MKI67-low tumors. Conclusions: MKI67 enrichment in PDAC correlates with aggressive tumor biology, enhanced proliferative signaling, genomic instability, and distinct microenvironmental and immune features. MKI67-high tumors demonstrate a reproducible association with proliferative signaling, genomic instability, and aggressive biological features across multiple transcriptomic datasets. Further validation is required to determine the clinical utility of MKI67 as a biomarker in PDAC.<\/jats:p>","DOI":"10.3390\/cancers18162631","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:48:36Z","timestamp":1786722516000},"page":"2631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MKI67 Enrichment Characterizes a Proliferative and Genomically Unstable Phenotype in Pancreatic Ductal Adenocarcinoma"],"prefix":"10.3390","volume":"18","author":[{"given":"Caleb Nathaniel","family":"Seavey","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2503-9350","authenticated-orcid":false,"given":"Kei","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"},{"name":"Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9174-4311","authenticated-orcid":false,"given":"Asama","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lise","family":"Di Lena","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-4241","authenticated-orcid":false,"given":"Kazuaki","family":"Takabe","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"},{"name":"Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"},{"name":"Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 980645, USA"},{"name":"Department of Surgery, University at Buffalo Jacob School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY 14203, USA"},{"name":"Department of Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8520, Japan"},{"name":"Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1426-1098","authenticated-orcid":false,"given":"Mashaal","family":"Dhir","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"ref_1","first-page":"e70043","article-title":"Cancer Statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"SEER (2026). Cancer Stat Facts: Pancreatic Cancer, National Cancer Institute."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving Outcomes of Patients with Pancreatic Cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fan, M., Deng, G., Ma, Y., Si, H., Wang, Z., and Dai, G. (2024). Survival Outcome of Different Treatment Sequences in Patients with Locally Advanced and Metastatic Pancreatic Cancer. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-11823-8"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic Analyses Identify Molecular Subtypes of Pancreatic Cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual Microdissection Identifies Distinct Tumor- and Stroma-Specific Subtypes of Pancreatic Ductal Adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jso.26510","article-title":"Predictors of Early Recurrence Following Neoadjuvant Chemotherapy and Surgical Resection for Localized Pancreatic Adenocarcinoma","volume":"124","author":"Narayanan","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/JS9.0000000000000296","article-title":"Early and Late Recurrence Patterns of Pancreatic Ductal Adenocarcinoma after Pancreaticoduodenectomy: A Multicenter Study","volume":"109","author":"Zhang","year":"2023","journal-title":"Int. J. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","article-title":"Ki-67 Gene Expression","volume":"28","author":"Uxa","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: More than a Proliferation Marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/PAS.0b013e31821a0696","article-title":"Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-Differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification","volume":"35","author":"Yang","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"He, X., Chen, Z., Fu, T., Jin, X., Yu, T., Liang, Y., Zhao, X., and Huang, L. (2014). Ki-67 Is a Valuable Prognostic Predictor of Lymphoma but Its Utility Varies in Lymphoma Subtypes: Evidence from a Systematic Meta-Analysis. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-153"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Davey, M.G., Hynes, S.O., Kerin, M.J., Miller, N., and Lowery, A.J. (2021). Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer. Cancers, 13.","DOI":"10.3390\/cancers13174455"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Li, B., Yin, X., Ding, X., Zhang, G., Jiang, H., Chen, C., Guo, S., and Jin, G. (2023). Combined Utility of Ki-67 Index and Tumor Grade to Stratify Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Upfront Surgery. BMC Surg., 23.","DOI":"10.1186\/s12893-023-02256-4"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs5.50175","article-title":"Prognostic Impact of Ki-67 Proliferative Index in Resectable Pancreatic Ductal Adenocarcinoma","volume":"3","author":"Pergolini","year":"2019","journal-title":"BJS Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.14740\/wjon1751","article-title":"High Ki67 Gene Expression Is Associated with Aggressive Phenotype in Hepatocellular Carcinoma","volume":"15","author":"Oshi","year":"2024","journal-title":"World J. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Pan, X., Wei, C., Su, J., Fang, M., Lin, Q., Qin, Y., Gao, J., Zhao, J., Zhao, H., and Liu, F. (2025). A Comprehensive Analysis of the Prognostic Value, Expression Characteristics and Immune Correlation of MKI67 in Cancers. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1531708"},{"key":"ref_18","first-page":"4294","article-title":"A Prognostic Score Based on Long-Term Survivor Unique Transcriptomic Signatures Predicts Patient Survival in Pancreatic Ductal Adenocarcinoma","volume":"11","author":"Katsuta","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.62347\/KQNW1871","article-title":"Insights into Autotaxin- and Lysophosphatidate-Mediated Signaling in the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment: A Survey of Pathway Gene Expression","volume":"14","author":"Benesch","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"ref_20","first-page":"3638","article-title":"Pancreatic Ductal Adenocarcinoma with a High Expression of Alcohol Dehydrogenase 1B Is Associated with Less Aggressive Features and a Favorable Prognosis","volume":"13","author":"Chida","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_21","first-page":"4235","article-title":"High Mesothelin Expression in Pancreatic Adenocarcinoma Is Associated with Aggressive Tumor Features but Not Prognosis","volume":"13","author":"Hagerty","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_22","first-page":"5403","article-title":"High Beta Integrin Expression Is Differentially Associated with Worsened Pancreatic Ductal Adenocarcinoma Outcomes","volume":"12","author":"Benesch","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100933","DOI":"10.1016\/j.patter.2024.100933","article-title":"TCGA-Reports: A Machine-Readable Pathology Report Resource for Benchmarking Text-Based AI Models","volume":"5","author":"Kefeli","year":"2024","journal-title":"Patterns"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Stratford, J.K., Bentrem, D.J., Anderson, J.M., Fan, C., Volmar, K.A., Marron, J.S., Routh, E.D., Caskey, L.S., Samuel, J.C., and Der, C.J. (2010). A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma. PLoS Med., 7.","DOI":"10.1371\/journal.pmed.1000307"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.14740\/wjon2009","article-title":"Angiogenesis Is Associated With Aggressive Biology That Counterbalances with Tumor Immunogenicity in Hepatocellular Carcinoma","volume":"16","author":"Vaghjiani","year":"2025","journal-title":"World J. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.14740\/wjon2529","article-title":"Invasive Lobular Carcinoma Has Higher Immune Response Than Invasive Ductal Carcinoma in Estrogen Receptor-Positive\/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers","volume":"16","author":"Yee","year":"2025","journal-title":"World J. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14740\/wjon1936","article-title":"Activity-Regulated Cytoskeleton-Associated Protein Gene Expression Is Associated with High Infiltration of Stromal Cells and Immune Cells, but With Less Cancer Cell Proliferation and Better Overall Survival in Estrogen Receptor-Positive\/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers","volume":"16","author":"Yee","year":"2025","journal-title":"World J. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14740\/wjon1993","article-title":"VEGFA Gene Expression in Breast Cancer Is Associated With Worse Prognosis, but Better Response to Chemotherapy and Immunotherapy","volume":"16","author":"Sharma","year":"2025","journal-title":"World J. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7555\/JBR.30.20150107","article-title":"Deciphering the Role of Hedgehog Signaling in Pancreatic Cancer","volume":"30","author":"Gu","year":"2016","journal-title":"J. Biomed. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ram Makena, M., Gatla, H., Verlekar, D., Sukhavasi, S., Pandey, M.K., and Pramanik, K.C. (2019). Wnt\/\u03b2-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174242"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1158\/0008-5472.CAN-12-4384","article-title":"Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and Dissemination Precede Pancreatic Tumor Formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Palamaris, K., Felekouras, E., and Sakellariou, S. (2021). Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance. Cancers, 13.","DOI":"10.3390\/cancers13215532"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/gutjnl-2013-306202","article-title":"Targeting mTOR Dependency in Pancreatic Cancer","volume":"63","author":"Morran","year":"2014","journal-title":"Gut"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102532","DOI":"10.1016\/j.tranon.2025.102532","article-title":"Integrated Transcriptome and Single-Cell RNA Sequencing Analysis Revealed the Prognostic Significance of GBP4 in Pancreatic Adenocarcinoma","volume":"61","author":"Chi","year":"2025","journal-title":"Transl. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/curroncol29040206","article-title":"Predicting Early Disease Recurrence of Pancreatic Cancer Following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker","volume":"29","author":"Hughes","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","article-title":"A Unifying Paradigm for Transcriptional Heterogeneity and Squamous Features in Pancreatic Ductal Adenocarcinoma","volume":"1","author":"Hayashi","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"18278","DOI":"10.1038\/s41598-020-74067-z","article-title":"Objective Assessment of Tumor Regression in Post-Neoadjuvant Therapy Resections for Pancreatic Ductal Adenocarcinoma: Comparison of Multiple Tumor Regression Grading Systems","volume":"10","author":"Matsuda","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/jnci\/djt306","article-title":"An International Ki67 Reproducibility Study","volume":"105","author":"Polley","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1200\/JCO.21.02616","article-title":"Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot","volume":"40","author":"Ullman","year":"2022","journal-title":"J. Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:46Z","timestamp":1787027026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":41,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162631"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162631","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}